WooGene B&G Co., Ltd (KOSDAQ: A018620)
Health Care · Pharmaceuticals · KR
₩2,610.00
+1.95% today · -35.9% 1Y
WooGene B&G Co., Ltd (KOSDAQ: A018620) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $13.06M.
Over the last twelve months the share price has lost 35.9%, trading between 2.12K and 4.36K.
Tweenvest scores WooGene B&G Co., Ltd across four factors: quality 59/100, value 64/100, growth 4/100. Its strongest factor is value.
A018620 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $13.06M
- Revenue (TTM)
- $35.97M
- P/E
- —
- EPS
- -309.98
- Dividend yield
- —
- Beta (5Y)
- 0.24
- 52-week high
- ₩4,358.33
- 52-week low
- ₩2,120.00
- Avg volume (3M)
- —
- Shares outstanding
- 6.93M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.